Clinical Trials

Gastrointestinal Stromal Tumors

NCT00961571 2025-02-12

Sunitinib and Capecitabine for First Line Colon Cancer

50 enrolled 7 charts

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Colorectal Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

2 enrolled

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT05751733 2023-03-02

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

Phase NA Recruiting

258 enrolled

Gastrointestinal Stromal Tumors

NCT00936832 2022-08-30

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Phase 2 Withdrawn

Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT03170180 2022-06-15

Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer

66 enrolled

Stomach Neoplasms

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02164240 2021-06-14

SURE

Phase 1 Completed

14 enrolled 8 charts

Gastrointestinal Stromal Tumors

NCT03909724 2020-11-13

SUNRISE-CRC

Phase 2/3 Unknown

60 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT02713763 2020-03-04

RESUNET

EndocrineGastrointestinal

11 enrolled

Pancreatic Neuroendocrine Tumour Metastatic

NCT03862768 2019-03-05

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Phase NA Unknown

92 enrolled

Gastrointestinal Stromal Tumors

NCT00806663 2019-02-06

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

22 enrolled

Colorectal Neoplasms

NCT00891878 2018-07-24

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

12 enrolled 12 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00524316 2017-05-09

Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

16 enrolled 11 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00400114 2017-05-08

Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer

36 enrolled

Esophageal Neoplasms, Neoplasms

NCT00702884 2017-03-21

Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer

25 enrolled 10 charts

Esophageal Neoplasms

NCT00730353 2017-03-16

Sutent + Taxol for Advanced Esophageal Cancer

28 enrolled 13 charts

Esophageal Neoplasms

NCT00361244 2017-02-17

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Phase 1/2 Terminated

6 enrolled

Colorectal Neoplasms

NCT01718327 2017-01-31

SUN-CK

53 enrolled

Cholangiocarcinoma

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

50 enrolled

BreastGastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Phase 2 Unknown

80 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT00524186 2016-06-21

Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer

Phase 1 Terminated

23 enrolled

GastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

54 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors

NCT01215578 2015-04-30

NET

EndocrineGastrointestinalNET

33 enrolled

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT01215565 2014-03-13

Fibrolam

4 enrolled

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT01238055 2013-04-09

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

116 enrolled

Advanced Gastric Cancer

NCT00400569 2012-08-28

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

48 enrolled 9 charts

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

NCT00514228 2012-06-26

Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

45 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00495625 2012-03-27

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

33 enrolled 11 charts

Liver Neoplasms

NCT00967603 2012-02-01

PACT-12

56 enrolled

Pancreatic Neoplasms

NCT00673504 2011-12-01

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

105 enrolled

Neoplasms, Pancreatic Neoplasms

NCT00573404 2011-11-16

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Phase 1 Terminated

6 enrolled